Recombinant purified tnfα

Recombinant purified TNFα, the annexin V-FITC antibody and the 7-AAD antibody were purchased from BioLegend (London, United Kingdom). Necrostatin-1_s (Nec-1_s) was obtained from BioVision, Inc. (Milpitas, CA, USA). The zVAD-fmk (herein referred to as zVAD) was purchased from Bachem (Weil, Germany). Erastin (era), GSK’872, Necrosulfonamide (NSA) and the anti-MLKL antibody (clone 3H1) were obtained from Calbiochem (Merck Millipore, Darmstadt, Germany). Synthesis of the ferrostatin derivative 16-86 and the ferroptosis inducer RSL3 were described previously [12 (link), 14 (link)]. Ferrostatin-1 (Fer-1) was purchased from Xcess Biosciences Inc. (San Diego, CA, USA). Dabrafenib was purchased from Selleckchem (Absource Diagnostics, Munich, Germany). GW806742X was purchased from Biomol (Hamburg, Germany). The monoclonal anti-ACSL4, anti-GPX4, the anti-human and anti-mouse monoclonal phospho-MLKL antibodies were all obtained from Abcam (Cambridge, United Kingdom). The β-actin antibody was purchased from Cell Signaling (Frankfurt, Germany).

Recombinant purified TNFα, annexin V-fluorescein isothiocyanate (FITC) antibody, and 7-amino-actinomycin D (7-AAD) antibody was obtained from BioLegend (London, United Kingdom). The zVAD-fmk (herein referred to as zVAD) was obtained from Bachem (Weil, Germany); erastin and 1S,3R-RSL3 (herein referred to as RSL3) obtained from Tocris, Bio-Techne (Wiesbaden, Germany).